SYK and stroke disorder: Mice treated with the Syk inhibitor BAY61-3606 before tMCAO, or 3 h after reperfusion, showed >50% decrease in infarct volume (Figure 1(h) and (i)) and greater functional scores than vehicle-treated mice (Figure 1(j)), supporting the efficacy of Syk inhibitors in this stroke model.